C
Corcept Therapeutics Incorporated
Q4 2025 earnings expected
Quarter
Oct – Dec
Expected
March 1, 2026(ET)
Revenue
This quarter$202M
Analyst estimate$257M▼ -21.3%
Year ago (Dec '24)$182M▲ +11.1%
EPS
This quarter$0.20
Analyst estimate$0.33▼ -39.3%
Year ago (Dec '24)$0.26▼ -23.1%
Revenue Growth Trajectory
+5%YoY
Last 6 quarters · 4 analysts